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rTATE-OF-THE-ART PAPER1435Acute RV Failureim Lahm, Charles A. McCaslin, Thomas C. Wozniak, Waqas Ghumman, Yazid Y. Fadl,
mar S. Obeidat, Katie Schwab, Daniel R. Meldrum
cute right ventricular (RV) failure is a frequent and serious clinical challenge. Lahm and
olleagues review the treatment options for isolated RV failure. Therapies should be directed
gainst the underlying cause of RV failure, along with supportive measures and judicious
olume management. Pulmonary artery catheters may be useful. Selective pulmonary
asodilators in conjunction with inotropes appears promising, particularly the combination of
nhaled nitric oxide and dobutamine. There is emerging evidence to recommend the use of
nhaled prostacyclins, and PDE-5 inhibitors may be beneficial because of selective actions on
he RV. Mechanical or surgical interventions are used as primary treatment for distinct
onditions or as rescue therapy, and include pulmonary thromboendarterectomy, isolated RV
ssist devices, and pulmonary transplant.CLINICAL RESEARCH NTIPLATELET THERAPY
1447he Effect of Aspirin and Clopidogrel Responsiveness
on Long-Term Outcomes After Elective PCIianluca Campo, Luca Fileti, Nicoletta de Cesare, Emanuele Meliga, Alessandro Furgieri,
ilippo Russo, Salvatore Colangelo, Salvatore Brugaletta, Roberto Ferrari, Marco Valgimigli,
n behalf of the 3T/2R Investigators
ampo and colleagues investigated the relationship between aspirin and clopidogrel
esponsiveness and long-term outcomes after elective percutaneous coronary intervention
PCI) in low-risk patients. Aspirin and clopidogrel response was measured with VerifyNow
spirin and P2Y12 assays (Accumetrics, San Diego, California), and subjects were followed
or 1 year for the composite end point of death, stroke, or myocardial infarction.
pproximately one-fourth of patients were poor responders to aspirin, but this did not
ncrease the risk of the composite end point after multivariable adjustment. Approximately
ne-third were clopidogrel poor responders, and these subjects were 2.5 times more likely to
xperience an ischemic event. In this study, poor response to clopidogrel is an independent
redictor of worse 1-year outcomes in low-risk patients undergoing PCI, whereas poor
esponse to aspirin is not predictive.(continued on page A-18)
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1456nhibitory Effects of Ticagrelor Compared With
Clopidogrel on Platelet Function in Patients With ACSobert F. Storey, Dominick J. Angiolillo, Shankar B. Patil, Bhaloo Desai, Rosemary Ecob, Steen Husted,
akan Emanuelsson, Christopher P. Cannon, Richard C. Becker, Lars Wallentin
his substudy of the PLATO (PLATelet inhibition and patient Outcomes) trial measured
he platelet inhibitory effects of ticagrelor and clopidogrel in acute coronary syndrome (ACS)
atients. Patients were randomized to receive either clopidogrel (300- to 600-mg loading dose
LD], 75-mg daily maintenance dose [MD]) or ticagrelor (180-mg LD, 90-mg twice-daily
D). Ticagrelor achieved greater suppression of platelet reactivity compared with clopidogrel
ased on light transmittance aggregometry for both the LD and the MD. The larger trial
howed a reduction in the composite end point of ischemic events, suggesting that the
tronger antiplatelet effect of ticagrelor is clinically effective.EART RHYTHM DISORDERS1463Periprocedural Corticosteroids May Prevent Early Recurrence of AF After Ablationakashi Koyama, Hiroshi Tada, Yukio Sekiguchi, Takanori Arimoto, Hiro Yamasaki, Kenji Kuroki,
akeshi Machino, Kazuko Tajiri, Xu Dong Zhu, Miyako Kanemoto-Igarashi, Aiko Sugiyasu,
eisuke Kuga, Yoshio Nakata, Kazutaka Aonuma
nflammation may cause acute atrial fibrillation (AF) recurrence after pulmonary vein isolation
PVI) procedures. Koyama and colleagues randomized 125 subjects who underwent PVI to
days of post-procedure corticosteroids or placebo. The prevalence of immediate AF
ecurrence (3 days after the PVI) was significantly lower in the corticosteroid group (7%)
han in the placebo group (31%). At 14 months, the AF-free rate was higher in the
orticosteroid group (85%) than in the placebo group (71%). Transient use of corticosteroids
fter AF ablation may be useful for preventing early AF recurrences and improving long-term
uccess.ditorial Comment: Bernard Belhassen, p. 1473REVENTIVE CARDIOLOGY1476Cardiorespiratory Fitness Is Related to the Risk of SCDari A. Laukkanen, Timo H. Mäkikallio, Rainer Rauramaa, Vesa Kiviniemi, Kimmo Ronkainen,
udhir Kurl
aukkanen and colleagues examined the relationship between cardiorespiratory fitness and
udden cardiac death (SCD) in a population-based sample of men 42 to 60 years of age
ollowed for 17 years. Cardiorespiratory fitness was defined by using respiratory gas exchange
nalyzer and maximal workload during cycle ergometer exercise test. As a continuous variable,
1 metabolic equivalent increase in cardiorespiratory fitness was associated with a 22%
ecreased risk of SCD. Cardiorespiratory fitness is a predictor of SCD.
ditorial Comment: Michael S. Lauer, p. 1484(continued on page A-22)
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EDULT CONGENITAL HEART DISEASE1486QRS Duration Predicts Outcomes After PVR Late After Tetralogy of Fallot Correctionoderick W. C. Scherptong, Mark G. Hazekamp, Barbara J. M. Mulder, Olivier Wijers,
ees A. Swenne, Ernst E. van der Wall, Martin J. Schalij, Hubert W. Vliegen
atients with tetralogy of Fallot who usually undergo surgical correction in childhood may
equire pulmonary valve replacement (PVR) approximately 20 years later. Scherptong and
olleagues analyzed whether QRS duration, before and after PVR, predicts long-term clinical
utcomes in these patients, as the QRS duration has been linked to right ventricle volume
nd ejection fraction. QRS duration was measured pre-operatively and 6 months after PVR.
fter multivariate correction, a post-operative QRS duration 180 ms and the absence of a
eduction in QRS duration post-PVR were associated with adverse outcomes at 5 years.
evere QRS prolongation, pre- or post-PVR, is a marker of high-risk patients in this
opulation.ARDIAC GENETICS1493Mutation in Nebulette Gene Linked to DCM and EFEnkhsaikhan Purevjav, Jaquelin Varela, Micaela Morgado, Debra L. Kearney, Hua Li, Michael D. Taylor,
akuro Arimura, Carole L. Moncman, William McKenna, Ross T. Murphy, Siegfried Labeit, Matteo Vatta,
eil E. Bowles, Akinori Kimura, Aladin M. Boriek, Jeffrey A. Towbin
urevjav and colleagues sought to determine if 4 variants (K60N, Q128R, G202R, and
592E) found in the nebulette gene of patients with dilated cardiomyopathy (DCM) and
ndocardial fibroelastosis (EFE) were causative. Transgenic mice with cardiac-restricted
verexpression of human wild-type or mutant nebulette were generated. Two of the variants
enerated lethal cardiac structural abnormalities in embryonic hearts (K60N and Q128R) and
he other 2 produced mice with left ventricular dilation and impaired function with specific
hanges in I-band and Z-disk proteins by 6 months of age. These results suggest that
ebulette is a new susceptibility gene for EFE and DCM.
ditorial Comment: Rashmi Ram, Burns C. Blaxall, p. 1503(continued on page A-24)
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pERIPHERAL ARTERIAL DISEASE1506ABI Useful for Risk Prediction Across Multiple Ethnicitiesichael H. Criqui, Robyn L. McClelland, Mary M. McDermott, Matthew A. Allison,
oger S. Blumenthal, Victor Aboyans, Joachim H. Ix, Greg L. Burke, Kaing Liu, Steven Shea
riqui and colleagues used data from the MESA (Multi-Ethnic Study of Atherosclerosis)
egistry to examine the association of both low and high ankle-brachial index (ABI) values
ith incident cardiovascular disease (CVD) events in a multiethnic cohort. Almost 7,000
on-Hispanic white, African-American, Hispanic, and Chinese men and women had
xtensive measures of traditional and newer biomarker risk factors, and measures of subclinical
VD, including the ABI. Both a low (1.00) and a high (1.40) ABI were associated with
ncident CVD events over a mean of 5.3 years. Sex- and ethnic-specific analyses showed
onsistent results, and these results remained significant after adjustment for both traditional
nd newer risk factors, including coronary artery calcium score and carotid intimal medial
hickness. In a primary prevention population, both a low ABI, diagnostic for peripheral
therosclerosis, and a high ABI, indicative of medial arterial calcification and possible
eripheral arterial disease, were associated with incident CVD events.
